HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions

This article was originally published in The Tan Sheet

Executive Summary

Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call

You may also be interested in...



Acetaminophen Recall Costs Perrigo $2.9 Mil.

Perrigo will take a $2.9 mil. earnings hit for recalling roughly 11 mil. bottles of acetaminophen after it found small metal fragments in some of the 500 mg caplets, the private labeler said

Leiner Posts Strong Q1 Sales Boosted By Joint, Heart Health Categories

Leiner Health Products' strong sales in the joint care, coenzyme Q10 and fish oil categories produced a 12.6% boost to $163.9 mil. in net sales for the first quarter of fiscal 2007 (ended June 24, 2006), the firm announced in a first quarter earnings call Aug. 8

Leiner Sees Gross Margins Improve, Brings Manufacturing In-House

Leiner Health Products' gross profit margins continue to improve, with consolidated gross profit margin "returning" to 24.5% for the fourth quarter of fiscal 2006, CEO Robert Kaminski announced during a fourth-quarter and full-year earnings call June 15

Related Content

Topics

UsernamePublicRestriction

Register

RS125404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel